Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Sarcoma × Methotrexate × Clear all

Phase

Status

Completed 7 Terminated 2 Withdrawn 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 16 Burkitt Lymphoma 10 Myelodysplastic Syndromes 6 Leukemia, Myeloid, Acute 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma, Mantle-Cell 4 Leukemia, Myeloid, Accelerated Phase 4 Leukemia, Biphenotypic, Acute 4 Blast Crisis 4 Lymphoma 3 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Leukemia, Myelomonocytic, Juvenile 2 Leukemia, Myeloid, Chronic-Phase 2 Leukemia 2 Graft vs Host Disease 2 Waldenstrom Macroglobulinemia 1 Urinary Bladder Neoplasms 1 Thrombocythemia, Essential 1 Solid Tumors 1 Sezary Syndrome 1 Sarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Primary Myelofibrosis 1 Precancerous Conditions 1 Polycythemia Vera 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1

Interventions

Radiotherapy 9 Nivolumab 9 pembrolizumab 8 Magnetic Resonance Spectroscopy 8 Doxorubicin 8 Specimen Handling 7 X-Rays 6 Cyclophosphamide 6 Biopsy 6 Phantoms, Imaging 5 Ipilimumab 5 talimogene laherparepvec 4 Radiation 4 Nuclear Medicine Department, Hospital 4 selpercatinib 3 pazopanib 3 palbociclib 3 cabozantinib 3 Sirolimus 3 Ifosfamide 3 Bevacizumab 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 olaparib 2 liposomal doxorubicin 2 larotrectinib 2 ivosidenib 2 entrectinib 2 ensartinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00470223 2025-06-08

OS2006

UNICANCER

Phase 3 Active not recruiting

Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡